Protein-coated microbeads provide a consistent approach for activating and expanding populations of T cells for immunotherapy but do not fully capture the properties of antigen presenting cells. In this report, we enhance T cell expansion by replacing the conventional, rigid bead with a mechanically soft elastomer. Polydimethylsiloxane (PDMS) was prepared in a microbead format and modified with activating antibodies to CD3 and CD28. A total of three different formulations of PDMS provided an extended proliferative phase in both CD4<sup>+</sup>-only and mixed CD4<sup>+</sup>–CD8<sup>+</sup> T cell preparations. CD8<sup>+</sup> T cells retained cytotoxic function, as measured by a set of biomarkers (perforin production, LAMP2 mobilization, an...
Much of what we know about the early stages of T cell activation has been obtained from studies of T...
Advances in the field of immunology have created many avenues for the development of novel immunothe...
Biomaterial-based scaffolds are promising tools for controlled immunomodulation. They can be applied...
Cells have long been known to sense and respond to mechanical stimuli in their environment. In the a...
Regulatory T cells (Tregs) provide an essential tolerance mechanism to suppress the immune response....
Artificial antigen presenting cells (aAPCs) are engineered platforms for T-cell activation. It has b...
Chimeric Antigen Receptor (CAR) T-cell therapy is an emerging immunotherapy that exhibits promising ...
Despite recent successes in cancer immunotherapies, challenges including insufficient activation and...
We present a simple cost-effective benchtop protocol to functionalize glass and polydimethylsiloxane...
The recent rise of adoptive T cell therapy (ATCT) as a promising cancer immunotherapy has triggered ...
Immune system functionality and lymphocyte activity are gaining traction as a relevant therapeutic s...
Firstly, this thesis presents the in vivo evaluation of a previously developed model system that uti...
137 pagesThe development of materials-based immune organs and scalable technologies are emerging fie...
Soft tissue loss can be the result of many clinical issues. An engineered injectable material to st...
Thesis (Ph.D.)--University of Washington, 2018Chimeric antigen receptor (CAR) T cell therapy has eme...
Much of what we know about the early stages of T cell activation has been obtained from studies of T...
Advances in the field of immunology have created many avenues for the development of novel immunothe...
Biomaterial-based scaffolds are promising tools for controlled immunomodulation. They can be applied...
Cells have long been known to sense and respond to mechanical stimuli in their environment. In the a...
Regulatory T cells (Tregs) provide an essential tolerance mechanism to suppress the immune response....
Artificial antigen presenting cells (aAPCs) are engineered platforms for T-cell activation. It has b...
Chimeric Antigen Receptor (CAR) T-cell therapy is an emerging immunotherapy that exhibits promising ...
Despite recent successes in cancer immunotherapies, challenges including insufficient activation and...
We present a simple cost-effective benchtop protocol to functionalize glass and polydimethylsiloxane...
The recent rise of adoptive T cell therapy (ATCT) as a promising cancer immunotherapy has triggered ...
Immune system functionality and lymphocyte activity are gaining traction as a relevant therapeutic s...
Firstly, this thesis presents the in vivo evaluation of a previously developed model system that uti...
137 pagesThe development of materials-based immune organs and scalable technologies are emerging fie...
Soft tissue loss can be the result of many clinical issues. An engineered injectable material to st...
Thesis (Ph.D.)--University of Washington, 2018Chimeric antigen receptor (CAR) T cell therapy has eme...
Much of what we know about the early stages of T cell activation has been obtained from studies of T...
Advances in the field of immunology have created many avenues for the development of novel immunothe...
Biomaterial-based scaffolds are promising tools for controlled immunomodulation. They can be applied...